Ottimo Pharma Emerges With An Ex-Seagen CEO And A PD1/VEGF Bispecific Contender

 
• By Andrew McConaghie
  
Cancer cells on scientific background.3d illustration
• Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Start-Ups & SMEs

More from Scrip